Identification of biomarkers, pathways and potential therapeutic agents for white adipocyte insulin resistance using bioinformatics analysis

References

• Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473–481.
   PubMed Web of Science ®Google Scholar
• Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7:14–24.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115: 911–919. quiz 920.
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679–689.
   PubMed Web of Science ®Google Scholar
• Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12:144–153.
   PubMed Web of Science ®Google Scholar
• Divella R, De Luca R, Abbate I, et al. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer. 2016;7:2346–2359.
   PubMed Web of Science ®Google Scholar
• Kim Y, Bayona PW, Kim M, et al. Macrophage lamin A/C regulates inflammation and the development of obesity-induced insulin resistance. Front Immunol. 2018;9:696.
   PubMed Web of Science ®Google Scholar
• Bluher M, Kloting N, Wueest S, et al. FasL expression in human adipose tissue is related to obesity, insulin resistance, and type 2 diabetes. J Clin Endocrinol Metab. 2014;99:E36–E44.
   PubMed Web of Science ®Google Scholar
• Liu L, Li Q, Xiao X, et al. miR-1934, downregulated in obesity, protects against low-grade inflammation in adipocytes. Mol Cell Endocrinol. 2016;428:109–117.
   PubMed Web of Science ®Google Scholar
• Reaven G. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res. 2005;2:105–112.
   PubMedGoogle Scholar
• Ghaben AL, Scherer PE. Adipogenesis and metabolic health. Nat Rev Mol Cell Biol. 2019;20:242–258.
   PubMed Web of Science ®Google Scholar
• Hardy OT, Perugini RA, Nicoloro SM, et al. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. Surg Obes Relat Dis. 2011;7:60–67.
   PubMed Web of Science ®Google Scholar
• Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110.
   PubMedGoogle Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882–883.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
   PubMed Web of Science ®Google Scholar
• Khomtchouk BB, Van Booven DJ, Wahlestedt C. HeatmapGenerator: high performance RNAseq and microarray visualization software suite to examine differential gene expression levels using an R and C++ hybrid computational pipeline. Source Code Biol Med. 2014;9:30.
   PubMedGoogle Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1–13).
   Web of Science ®Google Scholar
• Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808–D815.
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.
   PubMed Web of Science ®Google Scholar
• Bandettini WP, Kellman P, Mancini C, et al. MultiContrast delayed enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson. 2012;14:83.
   PubMed Web of Science ®Google Scholar
• Keller MP, Choi Y, Wang P, et al. A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res. 2008;18:706–716.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Narayan R, Corsello SM, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(6):1437–1452.e17.
   Web of Science ®Google Scholar
• Shah A, Mehta N, Reilly MP. Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr. 2008;32:638–644.
   PubMed Web of Science ®Google Scholar
• Orgel E, Mittelman SD. The links between insulin resistance, diabetes, and cancer. Curr Diab Rep. 2013;13:213–222.
   PubMed Web of Science ®Google Scholar
• Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr. 2011;3:12.
   PubMed Web of Science ®Google Scholar
• O’Connell J, Lynch L, Cawood TJ, et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One. 2010;5:e9997.
   PubMed Web of Science ®Google Scholar
• Cruz KJ, Morais JB, de Oliveira AR, et al. The effect of zinc supplementation on insulin resistance in obese subjects: a systematic review. Biol Trace Elem Res. 2017;176:239–243.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay T, Singh RR, Gupta S, et al. Bone morphogenetic protein-7 (BMP-7) augments insulin sensitivity in mice with type II diabetes mellitus by potentiating PI3K/AKT pathway. Biofactors. 2017;43:195–209.
   PubMed Web of Science ®Google Scholar
• Wentworth JM, Zhang JG, Bandala-Sanchez E, et al. Interferon-gamma released from omental adipose tissue of insulin-resistant humans alters adipocyte phenotype and impairs response to insulin and adiponectin release. Int J Obes (Lond). 2017;41:1782–1789.
   PubMed Web of Science ®Google Scholar
• Lin J, Li J, Huang B, et al. Exosomes: novel biomarkers for clinical diagnosis. ScientificWorldJournal. 2015;2015:657086.
   PubMedGoogle Scholar
• Hon KW, Abu N, Ab Mutalib NS, et al. Exosomes as potential biomarkers and targeted therapy in colorectal cancer: a mini-review. Front Pharmacol. 2017;8:583.
   PubMed Web of Science ®Google Scholar
• Yu Y, Du H, Wei S, et al. Adipocyte-derived exosomal MiR-27a induces insulin resistance in skeletal muscle through repression of PPARgamma. Theranostics. 2018;8:2171–2188.
   PubMed Web of Science ®Google Scholar
• Koeck ES, Iordanskaia T, Sevilla S, et al. Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease. J Surg Res. 2014;192:268–275.
   PubMed Web of Science ®Google Scholar
• Wang F, Chen FF, Shang YY, et al. Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE(-/-) mice. Int J Cardiol. 2018;265:181–187.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu Y, Guo J, et al. Adipocyte-derived exosomes promote lung cancer metastasis by increasing MMP9 activity via transferring MMP3 to lung cancer cells. Oncotarget. 2017;8:81880–81891.
   PubMedGoogle Scholar
• Pardo F, Villalobos-Labra R, Sobrevia B, et al. Extracellular vesicles in obesity and diabetes mellitus. Mol Aspects Med. 2018;60:81–91.
   PubMed Web of Science ®Google Scholar
• Chang SC, Yang WV. Hyperglycemia, tumorigenesis, and chronic inflammation. Crit Rev Oncol Hematol. 2016;108:146–153.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Zhang X, Zhang Y, et al. High glucose stimulates tumorigenesis in hepatocellular carcinoma cells through AGER-dependent O-glcNAcylation of c-jun. Diabetes. 2016;65:619–632.
   PubMed Web of Science ®Google Scholar
• Tinahones FJ, Coin-Araguez L, Mayas MD, et al. Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol. 2012;12:4.
   PubMedGoogle Scholar
• Unal R, Yao-Borengasser A, Varma V, et al. Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. J Clin Endocrinol Metab. 2010;95:2993–3001.
   PubMed Web of Science ®Google Scholar
• Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev. 2008;9:20–29.
   PubMed Web of Science ®Google Scholar
• Kobashi C, Asamizu S, Ishiki M, et al. Inhibitory effect of IL-8 on insulin action in human adipocytes via MAP kinase pathway. J Inflamm (Lond). 2009;6:25.
   PubMed Web of Science ®Google Scholar
• Hsieh PS, Jin JS, Chiang CF, et al. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring). 2009;17:1150–1157.
   PubMed Web of Science ®Google Scholar
• Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116:1494–1505.
   PubMed Web of Science ®Google Scholar
• Nduhirabandi F, Huisamen B, Strijdom H, et al. Role of melatonin in glucose uptake by cardiomyocytes from insulin-resistant Wistar rats. Cardiovasc J Afr. 2017;28:362–369.
   PubMed Web of Science ®Google Scholar
• Teodoro BG, Baraldi FG, Sampaio IH, et al. Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle. J Pineal Res. 2014;57:155–167.
   PubMed Web of Science ®Google Scholar
• Sharma S, Singh H, Ahmad N, et al. The role of melatonin in diabetes: therapeutic implications. Arch Endocrinol Metab. 2015;59:391–399.
   PubMed Web of Science ®Google Scholar
• Batumalaie K, Amin MA, Murugan DD, et al. Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation. Sci Rep. 2016;6:27236.
   PubMed Web of Science ®Google Scholar
• Abu Bakar MH, Azmi MN, Shariff KA, et al. Withaferin A protects against high-fat diet-induced obesity via attenuation of oxidative stress, inflammation, and insulin resistance. Appl Biochem Biotechnol. 2019;188:241–259.
   PubMed Web of Science ®Google Scholar
• Kleinridders A, Cai W, Cappellucci L, et al. Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci U S A. 2015;112:3463–3468.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Takamura N, Shuto T, et al. The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-alpha in mouse adipocytes. Biochem Biophys Res Commun. 2010;394:728–732.
   PubMed Web of Science ®Google Scholar